Ou W - Search Results

1

Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center.

Li N, Xu M, Li CF, Ou W, Wang BX, Zhang SL, Xu PF, Yuan C, Huang QA, Wang SY. Li N, et al. Among authors: ou w. Chin J Cancer. 2015 Sep 28;34(10):475-82. doi: 10.1186/s40880-015-0054-2. Chin J Cancer. 2015. PMID: 26411553 Free PMC article.

2

A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.

Wu Yl, Huang ZF, Wang SY, Yang XN, Ou W. Wu Yl, et al. Among authors: ou w. Lung Cancer. 2002 Apr;36(1):1-6. doi: 10.1016/s0169-5002(01)00445-7. Lung Cancer. 2002. PMID: 11891025 Clinical Trial.

3

Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.

Wang SY, Ye X, Ou W, Lin YB, Zhang BB, Yang H. Wang SY, et al. Among authors: ou w. Lung Cancer. 2009 May;64(2):238-43. doi: 10.1016/j.lungcan.2008.08.012. Epub 2008 Oct 5. Lung Cancer. 2009. PMID: 18838190

4

The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected locally advanced non-small cell lung cancer.

Sun HB, Wang SY, Ou W, Zhang BB, Yang H, Fang Q. Sun HB, et al. Among authors: ou w. Lung Cancer. 2010 Jun;68(3):403-8. doi: 10.1016/j.lungcan.2009.10.002. Epub 2009 Nov 12. Lung Cancer. 2010. PMID: 19913325 Clinical Trial.

5

[Clinical characteristics and prognosis of very young patients with breast cancer in the southern of China].

Yang H, Wang SY, Ou W, Sun HB, Fang Q. Yang H, et al. Among authors: ou w. Ai Zheng. 2009 Dec;28(12):1310-6. doi: 10.5732/cjc.009.10230. Ai Zheng. 2009. PMID: 19958627 Free article. Chinese.

6

[Discordance of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in non-small cell lung cancer].

Fang Q, Zhang L, Wang S, Ou W. Fang Q, et al. Among authors: ou w. Zhongguo Fei Ai Za Zhi. 2011 Jun;14(6):518-22. doi: 10.3779/j.issn.1009-3419.2011.06.07. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21645456 Free PMC article. Chinese.

7

Epidermal growth factor receptor mutation status and adjuvant chemotherapy in resected advanced non-small-cell lung cancer.

Sun HB, Ou W, Li Y, Fang Q, Qin J, Zhang L, Wang SY. Sun HB, et al. Among authors: ou w. Clin Lung Cancer. 2013 Jul;14(4):376-82. doi: 10.1016/j.cllc.2012.10.008. Epub 2013 Jan 4. Clin Lung Cancer. 2013. PMID: 23291256

8

A randomized phase 2 trial of erlotinib versus pemetrexed as second-line therapy in the treatment of patients with advanced EGFR wild-type and EGFR FISH-positive lung adenocarcinoma.

Li N, Ou W, Yang H, Liu QW, Zhang SL, Wang BX, Wang SY. Li N, et al. Among authors: ou w. Cancer. 2014 May 1;120(9):1379-86. doi: 10.1002/cncr.28591. Epub 2014 Jan 30. Cancer. 2014. PMID: 24481719 Free article. Clinical Trial.

9

Pemetrexed-carboplatin adjuvant chemotherapy with or without gefitinib in resected stage IIIA-N2 non-small cell lung cancer harbouring EGFR mutations: a randomized, phase II study.

Li N, Ou W, Ye X, Sun HB, Zhang L, Fang Q, Zhang SL, Wang BX, Wang SY. Li N, et al. Among authors: ou w. Ann Surg Oncol. 2014 Jun;21(6):2091-6. doi: 10.1245/s10434-014-3586-9. Epub 2014 Mar 1. Ann Surg Oncol. 2014. PMID: 24585406 Clinical Trial.

10

Meta-analysis of EGFR tyrosine kinase inhibitors compared with chemotherapy as second-line treatment in pretreated advanced non-small cell lung cancer.

Li N, Yang L, Ou W, Zhang L, Zhang SL, Wang SY. Li N, et al. Among authors: ou w. PLoS One. 2014 Jul 16;9(7):e102777. doi: 10.1371/journal.pone.0102777. eCollection 2014. PLoS One. 2014. PMID: 25029199 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

805 results

Search Page

Filters